Five Oceans Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$916K Sell
3,640
-27
-0.7% -$5.81K 0.29% 47
2026
Q1
$798K Buy
3,667
+4
+0.1% +$887 0.29% 42
2025
Q4
$837K Sell
3,663
-2
-0.1% -$456 0.3% 43
2025
Q3
$849K Sell
3,665
-107
-3% -$21.8K 0.31% 44
2025
Q2
$700K Buy
3,772
+22
+0.6% +$4.09K 0.3% 48
2025
Q1
$786K Buy
3,750
+35
+0.9% +$6.8K 0.38% 42
2024
Q4
$660K Sell
3,715
-561
-13% -$103K 0.3% 50
2024
Q3
$844K Sell
4,276
-6
-0.1% -$1.12K 0.4% 46
2024
Q2
$734K Sell
4,282
-730
-15% -$121K 0.39% 47
2024
Q1
$913K Sell
5,012
-52
-1% -$8.96K 0.47% 43
2023
Q4
$785K Sell
5,064
-64
-1% -$9.33K 0.44% 46
2023
Q3
$764K Buy
5,128
+21
+0.4% +$3.08K 0.49% 42
2023
Q2
$688K Sell
5,107
-74
-1% -$10.9K 0.44% 49
2023
Q1
$826K Sell
5,181
-357
-6% -$54.6K 0.53% 41
2022
Q4
$895K Buy
5,538
+97
+2% +$14.9K 0.62% 32
2022
Q3
$730K Buy
5,441
+855
+19% +$123K 0.58% 35
2022
Q2
$702K Buy
4,586
+1,394
+44% +$213K 0.52% 39
2022
Q1
$517K Buy
3,192
+134
+4% +$19.5K 0.46% 48
2021
Q4
$414K Buy
3,058
+164
+6% +$19.4K 0.37% 55
2021
Q3
$312K Buy
+2,894
New +$331K 0.36% 64

Other funds holding ABBV

Five Oceans Advisors's ABBV Position: Q2 2026 in Review

Five Oceans Advisors reduced its AbbVie (ABBV) stake by 0.74% in Q2 2026, selling an estimated $5.81K and leaving 3,640 shares worth $916K. The position accounts for 0.29% of the portfolio, ranked #47.

Five Oceans Advisors first reported a position in ABBV in Q3 2021 and has held it in 20 quarters since. 803 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Five Oceans Advisors held 3,640 shares of AbbVie worth $916K as of Q2 2026.
  • Five Oceans Advisors sold 27 AbbVie shares in Q2 2026, an estimated $5.81K.
  • AbbVie made up 0.29% of Five Oceans Advisors's portfolio in Q2 2026, its #47 holding.
  • Five Oceans Advisors first reported a position in AbbVie in Q3 2021 and has held it in 20 quarters since.
  • 803 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Five Oceans Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.